Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

The COVID-19 pandemic has exacerbated adversities associated with the working conditions of healthcare professionals, contributing to the deterioration of their physical and mental health, particularly as a result of work overload and daily stressors such as long working hours, low pay, lack of professional recognition, and high risk of infection. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

Dyslipidemia is considered as the most common risk factor for cardiovascular diseases, cerebrovascular diseases, and fatty liver disease. The available therapy aimed to decrease lipid profile and reduced long-term risk which do require lifelong therapy, hence adverse effects are suggestive Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

In response to the growing recognition of the importance of the quality care in psychiatric nursing, this study introduces the Psychiatric Nursing Care Quality Questionnaire (PNCQQ) designed to evaluate the quality of care provided to psychiatric patients from diverse cultural backgrounds. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

Maternal depression during pregnancy adversely affects offspring neurodevelopment and behaviour. Typical antide­pressants like selective serotonin reuptake inhibitors have limitations due to risks of crossing the placenta. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

The role of health systems and hospital administrative system in Covid-19 pandemic period is of utmost importance.
Objective: The scope of study is to assess the preparedness, response competencies of administrative staff and resilience of health system as well as to highlight the need of modernizing the role of the above three com­ponents. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

Introduction: Research on depression and emotional distress related to diabetes is limited, despite significant re­search activity in this area being evident from recent literature. However, it is crucial, as indicated by recent findings, to examine this correlation, which may be linked to the improvement of the quality of life of patients with diabetes. Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Issue 2

Open Access Clinical Study Gynecomastia treatment with tamoxifen or tamoxifen followed by letrozole: prototype clinical study Stefanos Zervoudis1,2,*, Georgios Iatrakis1,2, Panagiotis Tsikouras3, Panagiotis Peitsidis1,2, Angeliki Sarella2, Christos Ampatzis4 1Rea Maternity Hospital: Breast Unit, Athens, Greece 2 University of West Attica, Athens, Greece 3 University Hospital of Alexandroupolis, Greece 4 “St … Continue reading

Proceedings of the 1st Conference of the Hellenic Scientific Society of Aesthetics

  PHARMAKON-PRESS has published the “Proceedings of the 1st International Babylon Conference on Clinical and Experimental Pharmacological Research” that took place in Babylon (Hilah) in Iraq on the 4th and 5th of May 2024. The proceeding will be published on Scopus-indexed journal entitled “Review of Clinical Pharmacology and Pharmacokinetics – International Edition” (pISSN 1011-6583 • eISSN … Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

COVID-19 has been a global challenge caused by a coronavirus that infects the respiratory system and poses a high risk to life. This study dealt with some immunological indicators associated with this disease Continue reading

Review of Clinical Pharmacology and Pharmacokinetics – International Edition Volume 38 (2024) – Supplementary Issue 2

Nanoinformatics is a next-generation method for designing and simulating nanodrug candidates. It involves combining bioinformatics and quantum tools to predict and evaluate drugs. Continue reading